Skip to content

McCourt Marion

Reporting owner on Forms 3, 4 and 5, CIK 1663758.

McCourt Marion reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-18.

Issuers

IssuerRoles in the latest filingFilingsLast filed
REGN · REGENERON PHARMACEUTICALS, INC.CIK 872589officer (EVP Commercial)22026-11-18

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-44$952.7910,827Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-59$954.4610,768Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-30$955.5110,738Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-22$956.0110,716Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-44$958.4710,672Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-66$959.4610,606Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-49$960.3110,557Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-59$961.3610,498Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-41$962.4410,457Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-42$963.710,415Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-21$964.6910,394Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-63$965.6210,331Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-16S sold-26$971.9310,305Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding 219Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-10-30S sold-1,132$869.4310,871Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding 219Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001663758-26-000006 REGENERON PHARMACEUTICALS, INC.2026-11-18
Form 4 0001663758-26-000004 REGENERON PHARMACEUTICALS, INC.2026-11-03